Gout in the Foot and Ankle: Causes, Attacks, and Long-Term Management

In This Article

• What Is Gout and Why Does It Attack the Foot?
• Causes: Hyperuricemia and Crystal Formation
• Symptoms of a Gout Attack
• The Four Stages of Gout
• Diagnosis and Testing
• Acute Gout Attack Treatment
• Long-Term Urate-Lowering Therapy
• Diet and Lifestyle Modifications
• Best Foot Care Products for Gout
• Watch: Joint Pain Management
• Frequently Asked Questions
• Medical Sources
• Book Your Gout Evaluation

Affiliate disclosure: This article contains affiliate links to products we genuinely recommend. As an Amazon Associate, we earn from qualifying purchases at no extra cost to you.

What Is Gout and Why Does It Attack the Foot First?

Gout is a metabolic disease in which elevated blood levels of uric acid (hyperuricemia) lead to the formation and deposition of monosodium urate (MSU) crystals in joints and surrounding tissues. Uric acid is the end product of purine metabolism—purines are compounds found naturally in the body and in certain foods. When uric acid levels exceed the saturation threshold (approximately 6.8 mg/dL at normal body temperature), crystals begin to precipitate out of solution and deposit in joint spaces and soft tissues.

The first MTP joint of the great toe is the single most commonly affected joint in gout, involved in over 50% of initial attacks (podagra). This predilection is explained by several factors: the great toe joint is the coolest joint in the body (urate solubility decreases with temperature), it is subject to high mechanical stress from walking, it experiences significant pressure fluctuations during the gait cycle that may trigger crystal shedding from cartilage into the joint fluid, and it has relatively low blood flow during rest. Other frequently affected foot locations include the midfoot (tarsometatarsal joints), ankle, heel (Achilles tendon insertion), and lesser MTP joints.

Causes: Hyperuricemia and Crystal Formation

Hyperuricemia develops from either overproduction of uric acid (10% of cases), underexcretion by the kidneys (90% of cases), or a combination of both. Genetic factors play a significant role—multiple gene variants affecting renal urate transporters (particularly URAT1, GLUT9, and ABCG2) influence how efficiently the kidneys clear uric acid. This is why gout has a strong familial tendency, with first-degree relatives of gout patients having a 2-fold increased risk.

Modifiable risk factors include diet (high-purine foods like organ meats, shellfish, and red meat increase uric acid production), alcohol consumption (beer is particularly goutogenic due to its high guanosine purine content and because alcohol impairs renal urate excretion), fructose-sweetened beverages (fructose metabolism generates uric acid as a byproduct), obesity (visceral fat produces inflammatory cytokines that promote urate crystallization), and certain medications—particularly thiazide diuretics and low-dose aspirin that reduce renal urate clearance. Chronic kidney disease impairs uric acid excretion and is both a risk factor for and a consequence of untreated gout.

What Does a Gout Attack Feel Like? Symptoms and Presentation

A classic gout attack is one of the most painful experiences in medicine. The onset is typically sudden—often beginning in the middle of the night—with rapidly escalating pain that reaches maximum intensity within 12–24 hours. The affected joint becomes intensely red, hot, swollen, and exquisitely tender. Many patients describe the pain as unbearable: even the weight of a bedsheet on the toe or the vibration from someone walking across the room causes agony. The skin over the joint may appear shiny and taut, and the surrounding area can develop a dusky red or purplish hue.

Systemic symptoms including low-grade fever, malaise, and fatigue can accompany severe attacks. Without treatment, a typical acute flare resolves spontaneously over 7–14 days as the inflammatory response gradually subsides. However, some patients experience polyarticular attacks (multiple joints simultaneously) or attacks that last several weeks. Trigger events commonly precede gout attacks by 12–24 hours and include dietary indiscretion (a high-purine meal with alcohol), dehydration, acute illness, surgery, trauma to the joint, and starting or changing urate-lowering medications without prophylactic anti-inflammatory coverage.

The Four Progressive Stages of Gout

Gout follows a predictable natural history when not adequately treated. Stage 1 (asymptomatic hyperuricemia) involves elevated serum uric acid levels without any clinical symptoms—crystals are silently depositing in tissues. Stage 2 (acute gouty arthritis) brings the first clinical attacks, typically monoarticular and affecting the great toe. Between attacks, patients enter Stage 3 (intercritical gout)—asymptomatic periods between flares that initially last months to years but progressively shorten without treatment. Stage 4 (chronic tophaceous gout) develops after years of inadequately treated disease—permanent crystal deposits called tophi form visible nodules in and around joints, tendons, and bursae, causing chronic pain, joint destruction, and deformity.

Diagnosis and Testing for Gout

The gold-standard diagnosis is identification of negatively birefringent monosodium urate crystals in synovial fluid obtained through joint aspiration (arthrocentesis). Under polarized light microscopy, urate crystals appear as needle-shaped structures that are yellow when parallel to the compensator axis—a finding that is pathognomonic (definitively diagnostic) for gout. However, joint aspiration is not always practical or necessary—clinical diagnosis based on the classic presentation of acute monoarticular podagra with rapid onset, intense inflammation, and resolution within 1–2 weeks is highly accurate.

Serum uric acid levels support but do not confirm the diagnosis—uric acid is often paradoxically normal or even low during an acute attack because the inflammatory response transiently increases renal excretion. Check levels 2–4 weeks after an attack resolves for accurate baseline values. Imaging can assist diagnosis: X-rays may show characteristic “rat-bite” erosions with overhanging margins in chronic gout. Dual-energy CT (DECT) scanning can identify urate crystal deposits with high sensitivity and specificity without joint aspiration. Musculoskeletal ultrasound reveals the “double contour sign”—a hyperechoic line over cartilage representing crystal deposition—that is highly specific for gout.

Acute Gout Attack Treatment

The goal of acute treatment is rapid pain relief and inflammation control. First-line medications include NSAIDs (indomethacin, naproxen, or celecoxib) started at full dose immediately and continued for 5–7 days. Colchicine is most effective when started within the first 12–24 hours of an attack—the current guideline-recommended dose is 1.2 mg followed by 0.6 mg one hour later on day one, then 0.6 mg once or twice daily until the flare resolves. Corticosteroids (oral prednisone 30–40 mg daily for 5 days, or intra-articular injection of the affected joint) are excellent alternatives when NSAIDs and colchicine are contraindicated.

Supportive measures during an acute attack include strict rest with elevation of the affected foot, ice application for 20 minutes several times daily (with a cloth barrier to protect skin), adequate hydration (at least 2–3 liters of water daily to promote uric acid excretion), and avoiding tight footwear that compresses the inflamed joint. During a severe podagra attack, even a sock can be unbearable—open-toe sandals or going barefoot at home may be the only tolerable option. Do not start or change urate-lowering therapy during an acute flare, as fluctuations in uric acid levels can prolong or worsen the attack.

Long-Term Urate-Lowering Therapy

Once the acute attack resolves, the focus shifts to preventing future attacks through sustained reduction of serum uric acid below the crystallization threshold. The target is a serum urate level below 6.0 mg/dL—and below 5.0 mg/dL for patients with tophi. Allopurinol is the most commonly prescribed urate-lowering agent, starting at 100 mg daily and titrating upward every 2–4 weeks until the target is achieved (typical maintenance dose 200–400 mg daily). Febuxostat (Uloric) is an alternative xanthine oxidase inhibitor for patients who cannot tolerate allopurinol. Probenecid, a uricosuric agent that enhances renal uric acid excretion, may be used alone or in combination with xanthine oxidase inhibitors.

A critical principle is that initiating or adjusting urate-lowering therapy can paradoxically trigger gout attacks by mobilizing crystal deposits. Prophylactic anti-inflammatory coverage (low-dose colchicine 0.6 mg daily or an NSAID) should be co-prescribed for the first 3–6 months of urate-lowering therapy to prevent these mobilization flares. Patient adherence is the single biggest challenge in gout management—many patients stop medication once they feel better, not realizing that gout is a chronic metabolic disease requiring lifelong treatment to prevent progressive joint destruction.

Diet and Lifestyle Modifications for Gout

While diet alone rarely controls gout adequately without medication, dietary modifications complement pharmacotherapy and can reduce attack frequency. Limit high-purine foods including organ meats (liver, kidney), game meats, shellfish (shrimp, lobster, scallops), and certain fish (anchovies, sardines, herring). Eliminate or severely limit alcohol—particularly beer and spirits—as alcohol both increases uric acid production and reduces renal excretion. Eliminate fructose-sweetened beverages and minimize high-fructose corn syrup-containing products. Increase water intake to at least 2 liters daily to enhance urinary uric acid clearance.

Protective dietary factors include low-fat dairy products (which contain orotic acid that promotes renal urate excretion), cherries and cherry extract (which have modest urate-lowering and anti-inflammatory properties supported by clinical trials), coffee (associated with lower gout risk in epidemiologic studies), and vitamin C supplementation (500–1000 mg daily, which has mild uricosuric effects). Weight management through gradual, sustained weight loss reduces visceral adiposity and its associated inflammatory state—but avoid crash diets, which paradoxically raise uric acid through ketosis. Regular moderate exercise is beneficial, but intense exercise during dehydration can trigger attacks.

Best Foot Care Products for Gout Patients

Affiliate disclosure: The following section contains affiliate links to products we genuinely recommend. As an Amazon Associate, we earn from qualifying purchases at no extra cost to you.

PowerStep Pinnacle Arch-Supporting Insoles

PowerStep Pinnacle insoles help gout patients in two important ways. First, the arch support and deep heel cup redistribute weight-bearing forces away from the first MTP joint—the most common gout target—reducing the mechanical stress that can trigger crystal shedding and flares. Second, after chronic gout has caused structural damage to the great toe joint, PowerStep insoles accommodate the altered biomechanics and reduce compensatory loading on other foot structures. Between attacks, wearing PowerStep insoles in all shoes provides the consistent support that minimizes the mechanical provocation of a vulnerable joint.

Doctor Hoy’s Natural Pain Relief Gel

Doctor Hoy’s Natural Pain Relief Gel provides valuable complementary pain relief during gout attacks and for the residual joint soreness that lingers between flares. The arnica formula has natural anti-inflammatory properties, and the menthol delivers cooling relief to the intensely hot, inflamed joint. Apply gently to the affected area—during acute attacks, even gentle touch may be painful, so a thin application without pressure is recommended. Between attacks, Doctor Hoy’s helps manage the low-grade joint aching that many gout patients experience as the joint recovers. Unlike oral NSAIDs that may interact with gout medications or affect renal function, topical Doctor Hoy’s provides local relief without systemic concerns.

DASS Graduated Compression Socks

DASS graduated compression socks help between gout attacks by promoting circulation and reducing the dependent edema that can slow urate clearance from the lower extremity. Important: do not wear compression during an acute gout flare—the pressure on an intensely inflamed joint would be excruciating and counterproductive. Between attacks, DASS compression supports joint recovery, improves venous return, and helps maintain foot comfort during the walking and exercise that are essential components of gout management. The moisture-wicking fabric also helps keep feet dry and comfortable in the supportive shoes that gout patients need to wear consistently.

Watch: Understanding Joint Pain and Treatment

Frequently Asked Questions About Gout

Why does gout attack the big toe?

The first MTP joint of the great toe (podagra) is involved in over 50% of first gout attacks because it is the coolest joint in the body (urate crystallizes more readily at lower temperatures), it experiences high mechanical stress from walking, and it has relatively low blood flow during rest. The pressure changes during the gait cycle may trigger crystal shedding from cartilage into the joint fluid, initiating the inflammatory cascade.

Can gout be cured permanently?

Gout cannot be cured, but it can be extremely well controlled with lifelong urate-lowering therapy. Maintaining serum uric acid below 6.0 mg/dL dissolves existing crystal deposits over 6–24 months and prevents new crystal formation, effectively eliminating gout attacks. The key is consistent medication adherence—allopurinol or febuxostat must be taken daily for life. With proper treatment, most gout patients can become completely attack-free while living a normal diet and lifestyle.

What foods should I avoid with gout?

Limit or avoid high-purine foods including organ meats, game meats, shellfish, anchovies, sardines, and herring. Eliminate or severely limit alcohol (especially beer) and fructose-sweetened beverages. Beneficial foods include low-fat dairy, cherries, coffee, and plenty of water. However, diet alone rarely controls gout—medication is needed for reliable prevention. Focus on overall healthy eating with moderate portions rather than extreme dietary restrictions.

How do I tell gout apart from an infection?

Gout and septic arthritis (joint infection) can look identical—both cause sudden onset of an intensely red, hot, swollen, painful joint. This is why proper evaluation is essential. Features that suggest gout include a history of previous similar attacks, known hyperuricemia, typical first MTP joint location, and symptom onset overnight. Features that suggest infection include fever above 101°F, recent skin break or wound near the joint, an immunocompromised state, and a joint that has never been previously affected. When in doubt, joint aspiration with fluid analysis definitively distinguishes the two conditions.

Is gout a sign of kidney disease?

Gout and kidney disease have a bidirectional relationship. Chronic kidney disease reduces the kidneys’ ability to excrete uric acid, raising blood levels and increasing gout risk. Conversely, long-standing hyperuricemia and gout can cause urate nephropathy—uric acid crystal deposits within the kidney that impair function over time. Additionally, uric acid kidney stones affect approximately 10–20% of gout patients. This is why regular kidney function monitoring (serum creatinine, GFR) is recommended for all gout patients, and why maintaining uric acid levels in the normal range protects both your joints and your kidneys.

Medical Sources and References

1. FitzGerald JD, Dalbeth N, Mikuls T, et al. “2020 American College of Rheumatology guideline for management of gout.” Arthritis Care & Research. 2020;72(6):744-760.
2. Dalbeth N, Merriman TR, Stamp LK. “Gout.” The Lancet. 2016;388(10055):2039-2052.
3. Chen-Xu M, Yokose C, Rai SK, et al. “Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends.” Arthritis & Rheumatology. 2019;71(6):991-999.
4. Richette P, Doherty M, Pascual E, et al. “2016 updated EULAR evidence-based recommendations for the management of gout.” Annals of the Rheumatic Diseases. 2017;76(1):29-42.
5. Roddy E, Zhang W, Doherty M. “Are joints affected by gout also affected by osteoarthritis?” Annals of the Rheumatic Diseases. 2023;66(10):1374-1377.

Related Conditions and Resources

• Podiatrist-Recommended Foot Care Products 2026
• Bunion Surgery Recovery
• Diabetic Foot Care
• PAD and the Foot
• When to See a Podiatrist
• How Custom Orthotics Are Made

Your Board-Certified Podiatrists

Dr. Tom Biernacki, DPM

Board-Certified · FACFAS

Dr. Carl Jay, DPM

Board-Certified Podiatrist

Dr. Daria Gutkin, DPM

Podiatrist

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.